Learn more about the ongoing debate on the regulatory process for the new treatments for #Alzheimer ’s disease in #Europe: www.thelancet.com/journals/lan...

#AlzheimersTreatment #Lequembi #Donanemab #AmyloidTreatment #Lecanemab